Now livetag icon
AI created more apps than ever, but 75% won't make it. Find out how to win. Download the reportbanner icon
Biocept

May 2026

Biocept Market Share Analysis for May 2026

Year Founded1997
Employees51 - 200
Annual Revenue$75M - $100M
biocept.com
Biocept
Biocept (including company regionals)
  • biocept.com
    biocept.com
See more website traffic and engagement information

Biocept Revenue up to May 2026 is 75M - 100M

revenue generated by Biocept top domains

Biocept top domains revenue over 3 years

Revenue for Biocept top domains


Total visits to Biocept's top domains

Understand Biocept market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in Biocept's top domains

Analyze Biocept engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on Biocept's top domains

See how Biocept keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Biocept

These are the website technologies, by industry, used by Biocept top domains

Advertising (11)

DoubleClick

DoubleClick

Email Services (4)

G Suite

G Suite

Social (4)

Instagram

Instagram

Conversion & Analytics (3)

Google Analytics

Google Analytics

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Biocept

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPlus Therapeutics, Inc. partnered with Biocept, Inc. on Sep 1st '23.Plus Therapeutics Inc (NASDAQ: PSTV ) has expanded its supply agreement with Biocept Inc (NASDAQ: BIOC ) by acquiring an option to exclusively license Biocept's CNSide, a cerebrospinal fluid (CSF)-based tumor cell capture and enumeration platform, for patients receiving CNS radiotherapy.
NewsBiocept, Inc. hires Bruce E. Gerhardt as Board Vice Chair.The Biocept Board of Directors has appointed Bruce E. Gerhardt as Board Chair and Dr. Marsha A. Chandler as Board Vice Chair.

See all Biocept signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.